Clinical Trial: Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06886009) titled 'Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis' on March 19.

Brief Summary: The primary and secondary objectives are to respectively monitor the safety and effectiveness of Spesolimab IV in Korean patients with flares with generalized pustular psoriasis (GPP) in a routine medical practice.

Study Start Date: April 30

Study Type: OBSERVATIONAL

Condition: Generalized Pustular Psoriasis

Intervention: DRUG: Spevigo(R)

Intravenous

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Boehringer Ingelheim

Disclaimer: Curated by HT Syndication....